We have developed a foolproof method to substitute a stretch of residues by alanines. After the introduction of a PstI site by IPCR, thus creating two alanine codons, additional codons are introduced at this site through the use of an 'alanine-stretch cartridge'. These cartridges comprise an antibiotic resistance gene flanked on both sides by alanine codons. Excision of the resistance gene by PvuII then yields the correct insertion of codons. The method is both highly reliable and flexible and should be of general use.
Alanine-scanning mutagenesis is a simple and widely used technique in the determination of the catalytic or functional role of protein residues. Alanine is the substitution residue of choice since it eliminates the side chain beyond the β carbon and yet does not alter the main-chain conformation (as can glycine or proline) nor does it impose extreme electrostatic or steric effects (1) . Nonetheless, in case of systematic analysis of a protein, single amino replacements are quite laborious, so that direct substitution of a stretch of residues by alanines, or insertion of alanines become more effective. In order to avoid the drawbacks of the standard linker mutagenesis (cost of the oligonucleotides, low yield of insertion, no direct selection for linker insertions) we have developed an antibiotic resistance gene cartridge method which enables a foolproof phenotypic selection for the insertion of the alanines. Although any such mutagenesis could directly be performed by IPCR, the use of antibiotic cartridges has several advantages. It is more cost effective in case of systematic scanning. Our method is also perfectly foolproof whereas IPCR often yields incorrect insertions when used with very repetitive sequences such as alanine stretch sequences. Finally, the use of alanine stretch cartridges allows progressive insertion, as shown in the example below.
The outline of the method is as follows (Fig. 1) . Site-directed mutagenesis is first used to introduce a PstI restriction site in the sequence of the gene of interest. The IPCR mutagenesis method was chosen for its simplicity and high efficiency (2) . (It should be noted that the PstI and PvuII sites of the vector bearing the cloned gene have to be eliminated beforehand, since the method relies on the use of these sites). In the substitution approach, this site is introduced so that the first codon of the five substituted ones is replaced by the GCT codon, and that the last one is replaced by GCA. The first base of the sixth codon is substituted by a guanine in order to create a complete PstI site. In the insertion approach, the GCTGCA sequence is introduced between two codons, and the first base of the second codon is changed to a guanine.
Screening of the mutants bearing a single PstI site is readily performed by restriction analysis. Then, insertion of the stretch of alanine codons at this site is obtained through the use of a specially designed 'alanine-stretch cartridge'. This cartridge comprises kanamycin resistance gene (Kan R ) flanked on both sides by alanine codon sequences in which are embedded a PvuII and a PstI site (Fig. 1 ). Transformants expressing kanamycin resistance are easily selected for. Extracted plasmids from these strains are then digested by PvuII, ligated and transformed. The resulting clones are checked for there sensitivity to kanamycin and the plasmid DNA of one of these clones is sequenced. In all cases, the sequence showed the correct insertion of the alanine codons. The design of the cartridge is such that its insertion in both orientations will yield the right insertion of the alanine codons.
A second such cartridge has been created using the chloramphenicol resistance gene. This cartridge enables the insertion of four alanine codons (in addition to the two created by the PstI site) instead of three for the kanamycin one. Any kind of other cartridges can thus be constructed, in order to insert the desired number of alanines through the use of a single PstI site.
The insertion and substitution approaches have been tested on the TEM-1 β-lactamase. TEM-1 is one of the most commonly encountered plasmid-mediated β-lactamases, responsible for the hydrolysis of the β-lactam antibiotics, resulting in antibiotics resistance among many Gram-negative bacteria (3). The 3D structure of this protein (4) shows a 86-108 loop (between the h2 and h3 helix) which seems to be out of the catalytic core of the enzyme, and so should not play any role in the catalytic pathway. In order to check this hypothesis, a progressive alanine insertion has been realized in this loop. The PstI site has first been created at the L102 position, substituting the leucine for an alanine, and * To whom correspondence should be addressed at IPBS -CNRS, 205 Route de Narbonne, F-31077 Toulouse Cédex, France. Tel: +33 561 17 59 59; Fax: +33 561 17 59 94; Email: masson@ipbs.fr Figure 1 . Outline of the method, substitution approach. Construction of the chloramphenicol resistance gene cartridge: oligonucleotides 5′-TCGAG-CTGCAGCAGCTGGATATCTGAATGAAGATCTCAGCTGCTGCA-3′ and 5′-GCAGCTGAGATCTTCATTCAGATATCCAGCTGCTGCAGC-3′ were synthesised on an Applied Biosystem 380A. They were annealed in 100 mM NaCl. The resulting fragment was cloned between the XhoI and PstI sites of pBluescript (Stratagene, USA). A BstYI-XmnI fragment of pACYC184, including the chloramphenicol resistance gene, was cloned between the BglII and EcoRV sites of the modified pBluescript. The resulting vector was used as a source of the chloramphenicol resistance gene cartridge as a PstI fragment. Construction of the kanamycin resistance gene cartridge: oligonucleotides 5′-CAGTGGAGCTGCAGCAGCTGATCTCTGATGTTAC-3′ and 5′-GTTA-CGCTGCAGCTGGCGTTGTCGGGAAG-3′ were used in a PCR amplification of the kanamycin resistance gene from pACYC177. The PCR product was cut by PstI and cloned in pBluescript. The resulting vector was used as a source of the PstI kanamycin resistance gene cartridge.
inserting a second alanine. This variant has been called TEM 102-2A. Four additional alanines have been introduced with the chloramphenicol cartridge, leading to the creation of the TEM 102-6A variant. All the selected clones presented the correct sequences.
As expected, the strains expressing the TEM 102-2A or TEM 102-6A variants are resistant to ampicillin ( Table 1 ). The specific activities of the soluble enzymes were 19% (TEM 102-2A) and 13% (TEM 102-6A) respectively that of the wild type. Thus, inserting a two or six alanine stretch in the 86-108 loop of TEM-1 only has a minor impact on the enzymatic activity of the variants, confirming the minor role of this loop in the enzymatic process. In a second experiment, we substituted two turns of helix h5 of the TEM-1 enzyme by an alanine stretch. The 3D structure of TEM-1 hints that interactions between helix h5 and the main chain atoms of glutamic acid 166, a major catalytic residue, should play an important role in the enzymatic mechanism. The PstI site was introduced in place of codons 136-140, and the first base of codon 141 was changed to a G (resulting in a T141A modification). Three additional alanine codons were inserted thanks to the kanamycin cartridge, thus leading to an enzyme variant where residues 136-141 were replaced by alanines. Again, 100% of the selected clones exhibited the correct insertion. The strain expressing this TEM h5-6A mutant is sensitive to ampicillin (Table 1) . Immunoblotting revealed that only a fraction of the mutant enzyme was soluble (data not shown), the soluble fraction of this variant being totally devoid of enzymatic activity. The periplasmic solubility of the mutant is a positive indication, suggesting that it is correctly folded. Thus, this preliminary result is in line with the suspected role of the h5 helix.
Our alanine stretch mutagenesis method can be used as a probe to rapidly scan a whole protein sequence in search of secondary structures or to characterize the catalytic or functional role of a stretch of residues. It also provides a powerful tool for protein stability and folding studies. This can be especially useful for epitope mapping and to find permissive sites for insertion of foreign epitopes in a protein. This method is relatively simple, and highly reliable, as a simple screening can be performed at each step. It offers a rapid way of introducing multiple alanine substitutions or insertions and its flexibility is such that it should be of general application.
